Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Disappointing Day
View:
Post by Ingiboy on Feb 21, 2023 8:17pm

Disappointing Day

Was hoping to move above $.20 today but it was not to be:

Recent Trades - Last 10 of 13
Time ET Ex Price Change Volume Buyer Seller Markers
15:38:45 O 0.17 -0.02 2,500 1 Anonymous 1 Anonymous K
15:38:45 H 0.17 -0.02 3,000 1 Anonymous 1 Anonymous K
15:38:45 V 0.17 -0.02 2,500 2 RBC 1 Anonymous K
15:38:45 U 0.17 -0.02 2,000 2 RBC 1 Anonymous K
10:33:37 H 0.17 -0.02 1,000 1 Anonymous 80 National Bank K
10:29:26 H 0.17 -0.02 500 1 Anonymous 80 National Bank K
10:25:20 D 0.17 -0.02 300 80 National Bank 80 National Bank E
09:37:45 O 0.17 -0.02 500 1 Anonymous 80 National Bank K
09:32:10 M 0.17 -0.02 1 7 TD Sec 85 Scotia  
09:30:05 D 0.19   3 14 Virtu ITG 7 TD Sec E
 

The age old problem with penny stocks is the "penny flippers" who show up when you get a move like we had last week.

Comment by Genie29j on Feb 21, 2023 10:16pm
Hate to say it, but any trades right now are meaningless until there is tangible news. Until then, these trades are purely noise 
Comment by Ingiboy on Feb 22, 2023 11:35am
I am not sure about you but I would be rather launching from $.25 than $.15 when tangible news does occur.  I think there will be some interesting updates coming out of this AGM.
Comment by BellEnd on Feb 22, 2023 12:23pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Feb 22, 2023 12:36pm
Not sure where you got your information regarding the Dermal Injector testing.  Regardless, the device is now at the commercial grade level.  No more adjustments to be made.   I assume we will hear the timeline for the submission to the FDA.  Also questions will be asked at the meeting regarding which countries will be launching the device other than China/Hong Kong and the ...more  
Comment by BellEnd on Feb 22, 2023 12:52pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Feb 22, 2023 1:11pm
Hey Bullshite settle down.  No need for  that type of response.   I am not sure how you are interpreting "On or before Q2" but before Q2 could actually mean Q1 which only has one month left. We will see how this AGM plays out and we can revisit the "hypotheticals" .
Comment by BellEnd on Feb 22, 2023 1:13pm
This post has been removed in accordance with Community Policy
Comment by Genie29j on Feb 22, 2023 10:18pm
Simmerdown, Bellend 
Comment by BellEnd on Feb 23, 2023 8:08am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities